
Navid Mahmoodzadegan
About Navid Mahmoodzadegan
Navid Mahmoodzadegan is Co‑Founder and Chief Executive Officer of Moelis & Company (effective October 1, 2025) and serves on the Board of Directors; he previously was Co‑President since September 2015 and a Managing Director since 2007. He is 55, holds an A.B. with Highest Distinction from the University of Michigan (Phi Beta Kappa) and a J.D. from Harvard Law School, magna cum laude . 2024 firm performance considered by the Compensation Committee included adjusted revenues of $1.2 billion and a 37% one‑year TSR, with long‑term returns of 234% over five years and 525% since IPO; in 2025 Q3, revenue rose to $356.9 million GAAP and adjusted pre‑tax margin improved to 22.2% versus 9.5% YoY, underscoring momentum into his CEO tenure . Management notes quarterly results can be volatile due to transaction timing, cautioning against extrapolation .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Moelis & Company | Co‑President; Managing Director | Co‑President since Sep 2015; MD since 2007 | Co‑led global IB business; built Energy and Capital Structure Advisory; led global Media/Telecom/Tech franchise; direct revenue contributions; oversight of risk procedures |
| UBS | Global Head of Media Investment Banking; member, IB Americas Exec Committee | 2001–2007 | Led sector franchise; senior leadership within UBS IB Americas |
| Donaldson, Lufkin & Jenrette | Investment banker | 1995–2001 | M&A/sector coverage experience |
| Irell & Manella | Attorney | Early career (pre‑1995) | Legal training grounding later advisory career |
External Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Taft School | Board of Trustees | Current | Education governance and strategy |
| Carlthorp School | Board Chair, Board of Trustees | Prior service | Non‑profit leadership |
| JumpStart (National Board) | Director | Prior service | Education non‑profit oversight |
Fixed Compensation
| Year | Base Salary ($) | Cash Bonus ($) | Notes |
|---|---|---|---|
| 2024 | 400,000 | 2,130,000 | Bonus paid following year; reflects 2024 performance |
| 2023 | 400,000 | 3,000,000 | |
| 2022 | 400,000 | 5,000,000 |
| Employment agreement term | Key provision | Details |
|---|---|---|
| Base salary | $400,000 annually | Semi‑monthly payroll; reductions only if generally applied to majority of U.S. MDs |
| Annual incentive | Discretionary | Committee‑approved; contingent on firm and individual performance; paid per MD schedule |
| Benefits/perqs | Aircraft reimbursement | Reimbursement for business use of private aircraft; standard benefits/401(k) |
| Employment | At‑will | Termination by either party; CEO reports to Board; primary office Los Angeles |
| Notice | 180 days | Executive must provide 180‑day notice to resign; company may waive/put on paid leave |
Performance Compensation
| Year | Equity award type | Grant date | Units (#) | Grant date fair value ($) | Vesting / delivery schedule |
|---|---|---|---|---|---|
| 2025 (for 2024 perf) | Deferred LP Units | Feb 13, 2025 | 184,519 | 704,520 (CFO example) / 15,522,200 combined for Navid’s awards; note: Navid total includes 184,519 Deferred LP Units + 51,007 Restricted LTI LP Units | Deferred units eligible for redemption: 40% on/about Feb 23, 2027; 20% each of Feb 23, 2028–2030 |
| 2025 (for 2024 perf) | Restricted LTI LP Units | Feb 13, 2025 | 51,007 | Included in $15,522,200 total for 2025 grants | Time‑vest 33% on each of Feb 23, 2028–2030 |
| 2024 (for 2023 perf) | Restricted LP Units | Feb 15, 2024 | 166,526 | Included in $9,387,071 2024 stock awards line | 40% on Feb 23, 2026; 20% on Feb 23 of 2027–2029 |
| 2024 (for 2023 perf) | Restricted LTI LP Units | Feb 15, 2024 | 2,744 | Included in $154,679 | Equal installments on Feb 23, 2028 and Feb 23, 2029 |
| 2023 (for 2022 perf) | Restricted LP Units | Feb 2023 | 253,996 | Included in 2023 stock awards | 40% on Feb 23, 2025; 20% each on Feb 23 of 2026–2028 |
| 2022 (for 2021 perf) | Restricted LP Units | Feb 2022 | 85,085 | Included in 2022 stock awards | Equal installments Feb 23 of 2025–2027 |
| 2021 (for 2020 perf) | Restricted LP Units | Feb 2021 | 60,842 | Included in 2021 stock awards | Equal installments Feb 23, 2025 and Feb 23, 2026 |
| 2019/2020 | RSUs + dividend equivalents | Feb 2020 grant; dividends accrued | 39,565 + 17,444 dividend equivalents | n/a | 100% on Feb 23, 2025 |
| 2025 CEO Performance Units (one‑time award) | Metric / trigger | Target | Earned Units (#) | Measurement / service vesting |
|---|---|---|---|---|
| Dividend‑adjusted 20‑day VWAP | $86.00 | 150,000 | Quarterly measurement; highest VWAP during performance period; time‑vest equal installments on 3rd, 4th, 5th anniversaries of Sept 30, 2025 (Effective Date); linear interpolation between tiers | |
| Dividend‑adjusted 20‑day VWAP | $115.00 | 300,000 | As above | |
| Dividend‑adjusted 20‑day VWAP | $144.00 or greater | 450,000 | As above | |
| Change‑in‑control treatment | Price paid in transaction | Tests performance condition at deal price; service condition deemed achieved if employed at change‑in‑control; unvested non‑earned units forfeited | ||
| Termination provisions | Without Cause / Good Reason | Eligible to vest at greater of earned units to date or 225,000 earned units (subject to performance achievement) with continued vesting per schedule, contingent on no “Detrimental Activities” |
| Annual incentive performance framework (qualitative) | Weighting | Target | Actual | Payout determination |
|---|---|---|---|---|
| Firmwide adjusted revenues, operating margins, adjusted net income, TSR; strategic initiatives; peer benchmarking | Discretionary (no explicit weights disclosed) | Not disclosed | 2024 highlights: adjusted revenues ~$1.2B; 37% one‑year TSR; long‑term returns 234% (5‑yr) and 525% since IPO; peer group used for benchmarking (EVR, HLI, LAZ, PWP, PJT) | Committee discretion; equity allocation emphasized; CEO incentive pay delivered ~100% in equity |
Equity Ownership & Alignment
| Item | Amount | Notes |
|---|---|---|
| Beneficial ownership – Class A shares | 197,602; ~0.3% of Class A | As of April 9, 2025; excludes LP Units/RSUs not yet delivered |
| Class B shares | 0 | Partner Holdings (controlled by Ken Moelis) holds all Class B; 37% voting power |
| Unvested stock awards (units) | 735,853 | As of 12/31/2024; market value $54,364,805 at $73.88 per share |
| Equity incentive units unearned | 30,555 | Payout value $2,257,373 (market/payout) |
- Ownership guidelines and alignment: NEOs own equity >5x base salaries; multi‑year vesting/deferral (five‑year schedules) designed to align and promote retention; hedging and pledging of company stock are prohibited; clawback policy complies with SEC/NYSE rules .
- Insider selling pressure: Significant scheduled deliveries/vesting occur on Feb 23 each year (2025–2030) across legacy Restricted LP Units and RSUs; 2025 grants deliver starting 2027; CEO Performance Units vest on 3rd/4th/5th anniversaries of Sept 30, 2025 if price hurdles are achieved .
Employment Terms
| Provision | Detail |
|---|---|
| Contract type | At‑will; CEO, reports to Board; Effective Date Oct 1, 2025; LA office |
| Base salary | $400,000; semi‑monthly |
| Annual bonus | Discretionary; performance‑based; Committee approval |
| Non‑compete | During employment; if Executive resigns or terminated for Cause, 90 days post‑termination; passive stakes up to 1% permitted with notice |
| Non‑solicit (clients) | 12 months post‑termination; prohibits solicitation/interference |
| Non‑solicit (employees) | 12 months post‑termination |
| Notice to resign | 180 days; company may waive/place on paid leave |
| Aircraft reimbursement | Business use reimbursed |
| Clawback & insider trading | NYSE‑required clawback; hedging and pledging prohibited per policy |
| Section 409A, law & arbitration | Section 409A compliance; Delaware law; arbitration per partnership agreement |
Board Governance
- Board service history: Director April 2014–April 2021; rejoined Board effective October 1, 2025 with transition to CEO .
- Committee roles: MC’s Audit, Compensation, and Nominating & Corporate Governance Committees are entirely independent; current members are independent directors (Mirrer, Shropshire, Worrell); as an executive director, Navid is not described as serving on these committees .
- Independence and dual‑role implications: As CEO and director, Navid is not independent under NYSE standards; firm has a majority‑independent Board and a Lead Independent Director to balance governance; Chair role is held by Ken Moelis (Executive Chairman), mitigating CEO/Chair concentration concerns .
- Voting control context: Partner Holdings (controlled by Ken Moelis) holds Class B shares with 10:1 voting; company is no longer a “controlled company” and complies with NYSE independence requirements; Partner Holdings retains certain nomination rights subject to independence constraints .
Multi‑Year Compensation Summary (NEO – Navid Mahmoodzadegan)
| Year | Salary ($) | Cash Bonus ($) | Stock Awards ($) | All Other ($) | Total ($) |
|---|---|---|---|---|---|
| 2024 | 400,000 | 2,130,000 | 9,541,750 | 27,177 | 12,098,927 |
| 2023 | 400,000 | 3,000,000 | 13,554,171 | 45,300 | 16,999,471 |
| 2022 | 400,000 | 5,000,000 | 9,960,423 | 57,856 | 15,418,279 |
Performance & Track Record
- 2024: Compensation decisions considered adjusted revenues of ~$1.2B, firmwide execution of strategic investments, and 37% annual TSR; peer benchmarking against boutique banks guided committee judgment without fixed targets .
- 2025 YTD: Q3 GAAP revenues $356.9M; nine months GAAP revenues $1,028.9M; adjusted pre‑tax margin Q3 2025 22.2% vs 9.5% prior year; dividend declared $0.65/share; buybacks of 0.2M shares for $14.5M; strong cash/short‑term investments $619.9M, no debt .
- Volatility caution: Management highlights quarterly fluctuations from transaction timing; non‑GAAP reconciliations provided .
Compensation Structure Analysis
- Equity‑heavy pay mix with five‑year vesting/deferral longer than peers; CEO’s 2024 incentive delivered ~100% in equity, reinforcing long‑term alignment .
- 2025 CEO Performance Units add explicit stock price hurdles with staged time‑vesting, materially tying realized pay to shareholder returns .
- No option grants; program avoids option‑like instruments; grants occur post‑year with Committee discretion .
- Clawback policy in place; hedging/pledging prohibited, reducing misalignment risks .
Related Party Transactions and Governance Context
- Partner Holdings rights and dual‑class structure confer significant influence over major corporate actions and board nominations while the company maintains NYSE majority‑independent board status; mitigants include lead independent director and committee independence .
Equity Ownership & Vesting Schedule Detail (Upcoming Supply Considerations)
| Vesting/delivery date | Instrument | Units (#) | Notes |
|---|---|---|---|
| Feb 23, 2025 | RSUs + dividend equivalents (2019 award) | 39,565 + 17,444 | 100% vest |
| Feb 23, 2025 | Restricted LP Units (2023 award) | 253,996: 40% tranche (~101,598) | Remaining 20% tranches 2026–2028 |
| Feb 23, 2025–2027 | Restricted LP Units (2022 award) | 85,085 over equal installments | 2025–2027 |
| Feb 23, 2026–2029 | Restricted LP Units (2024 award) | 166,526: 40% in 2026; 20% each 2027–2029 | |
| Feb 23, 2028–2029 | Restricted LTI LP Units (2024 award) | 2,744: equal installments | |
| Feb 23, 2028–2030 | Restricted LTI LP Units (2025 award) | 51,007: 33% annually | |
| Feb 23, 2027–2030 | Deferred LP Units (2025 award) | 184,519: 40% in 2027; 20% each 2028–2030 | Delivery subject to non‑compete restrictions |
| Sept 30, 2028–2030 anniversaries | CEO Performance Units (2025 award) | Earned Units per VWAP tiers (150k/300k/450k) | Vest equal installments on 3rd, 4th, 5th anniversaries of Sept 30, 2025, subject to no “Detrimental Activities” |
Compensation Peer Group (Benchmarking)
- Peer set used for comparative performance and pay practices: Evercore, Houlihan Lokey, Lazard, Perella Weinberg Partners, PJT Partners; no explicit percentile/targets; one‑year boutique peers TSR averaged 56% vs MC’s 37%; long‑term returns exceed peers and major indices .
Say‑on‑Pay & Shareholder Feedback
- Directors elected by majority of votes cast; company emphasizes accountability and independence; general meeting voting requirements summarized; Partner Holdings retains certain rights but company adheres to NYSE independence standards .
Investment Implications
- Pay‑for‑performance alignment: CEO Performance Units with aggressive VWAP hurdles materially link realized equity to share price outcomes; expect limited near‑term supply from these units, with vesting only after hurdles and time conditions are met .
- Retention risk mitigants: Five‑year vest/deferral on core equity grants, 180‑day resignation notice, non‑compete/non‑solicit provisions, and clawback reduce flight risk and misalignment; termination rules allow continued vesting only if no “Detrimental Activities” occur .
- Trading signals: Concentrated vesting dates (Feb 23 annually) and 2027–2030 delivery windows may create episodic supply; monitoring Form 4 filings around these dates is prudent; buybacks and regular dividend ($0.65) support capital return and can offset delivery supply .
- Governance balance: Executive director role alongside an Executive Chairman within a majority‑independent board structure and robust anti‑hedging/pledging policies are positives; dual‑class control persists via Partner Holdings, warranting continued attention to shareholder rights dynamics .